Health

Early breast-cancer detection, through saliva.

Early Detection Nanotechnology markets a non-invasive test for the early detection of breast cancer from a saliva sample. The technology — patented and developed by UASLP together with the University of Texas at San Antonio — uses silver nanoparticles as an early-warning method. Being non-invasive, low-cost and applicable even at collection centers or remotely, it broadens access to detection and complements existing methods.

• Non-invasive test, via saliva.
• Patented technology (UASLP + UT San Antonio).
• High social impact: broadens access to early detection.
• Complements existing methods; can be applied periodically.